Research map: Lipoprotein(a) and Outcomes in Familial Hypercholesterolemia

Back to the article

Papers in this map

  1. Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies · Stephen Burgess · 2018 · 699 citations · Cited by this paper
  2. The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention · 2026 · Related
  3. Familial hypercholesterolaemia · Joep C. Defesche · 2017 · 546 citations · Cited by this paper
  4. Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · 2026 · Related
  5. Lipoprotein(a) Levels in Familial Hypercholesterolemia · Rodrigo Alonso · 2014 · 370 citations · Cited by this paper
  6. Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · 2026 · Related
  7. Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis · Harpreet Singh Bhatia · 2024 · 109 citations · Cited by this paper
  8. Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · 2026 · Related
  9. What Is the Prevalence of Familial Hypercholesterolemia? · Liam R. Brunham · 2021 · 24 citations · Cited by this paper
  10. Cardiovascular prevention in childhood and young adults · 2026 · Related
  11. Lipoprotein(a) in clinical practice: What clinicians need to know · Astefanos Al-Dalakta · 2025 · 2 citations · Cited by this paper
  12. Rethinking how we characterize the exercise blood pressure response in athletes · 2026 · Related
  13. Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · 2026 · Related
  14. Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · 2026 · Related
  15. Safe hearts need a healthy environment: prevention beyond our clinic walls · 2026 · Related
  16. Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · 2026 · Related

Source: OpenAlex (CC0)